These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28388387)

  • 41. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
    Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
    Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.
    Furuta T; Graham DY
    Gastroenterol Clin North Am; 2010 Sep; 39(3):465-80. PubMed ID: 20951912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Illusions regarding
    Graham DY
    Gut; 2017 Dec; 66(12):2043-2046. PubMed ID: 28935677
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical significance of Helicobacter pylori infection].
    Maev IV; Samsonov AA; Andreev DN; Grechushnikov VB; Korovina TI
    Klin Med (Mosk); 2013; 91(8):4-12. PubMed ID: 24437177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori treatment: Still a work in progress.
    Senatore FJ; Wilmot J; Birk JW
    Postgrad Med; 2016 Jan; 128(1):152-7. PubMed ID: 26490697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
    Gisbert JP; Molina-Infante J; Amador J; Bermejo F; Bujanda L; Calvet X; Castro-Fernández M; Cuadrado-Lavín A; Elizalde JI; Gene E; Gomollón F; Lanas Á; Martín de Argila C; Mearin F; Montoro M; Pérez-Aisa Á; Pérez-Trallero E; McNicholl AG
    Gastroenterol Hepatol; 2016 Dec; 39(10):697-721. PubMed ID: 27342080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [First line eradication treatment of Helicobacter pylori in 2019].
    Gressot P; Frossard JL; Grosgurin O; Marti C
    Rev Med Suisse; 2019 Oct; 15(667):1854-1858. PubMed ID: 31617972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New therapeutic strategies against Helicobacter pylori].
    Kang BK; Park SM; Kim BW
    Korean J Gastroenterol; 2014 Mar; 63(3):146-50. PubMed ID: 24651587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of
    Suzuki S; Esaki M; Kusano C; Ikehara H; Gotoda T
    World J Gastroenterol; 2019 Apr; 25(16):1907-1912. PubMed ID: 31086459
    [No Abstract]   [Full Text] [Related]  

  • 50. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Chey WD; Leontiadis GI; Howden CW; Moss SF
    Am J Gastroenterol; 2017 Feb; 112(2):212-239. PubMed ID: 28071659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The several problems and cautions in treatment of Helicobacter pylori infection].
    Fukuda Y; Sakagami T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1465-74. PubMed ID: 15508434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
    Graham DY; Lee SY
    Gastroenterol Clin North Am; 2015 Sep; 44(3):537-63. PubMed ID: 26314667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.
    Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O
    BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of Helicobacter pylori infection.
    Costa F; D'Elios MM
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helicobacter pylori treatment: antibiotics or probiotics.
    Goderska K; Agudo Pena S; Alarcon T
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):1-7. PubMed ID: 29075827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy.
    de Boer WA; Borody TJ
    Dig Liver Dis; 2000 Nov; 32(8):673-5. PubMed ID: 11142575
    [No Abstract]   [Full Text] [Related]  

  • 57. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
    Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
    Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Trend in the Eradication Rates of
    Park JS; Park JE; Oh BS; Yoon BW; Kim HK; Lee JW; Kim NH; Cho WS; Woo YS; Jahng J; Kim YS
    Korean J Gastroenterol; 2017 Nov; 70(5):232-238. PubMed ID: 29161792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. By the way, doctor. I was treated for two weeks with antibiotics and a proton pump inhibitor when I had an H.pylori infection. I've continued with the proton inhibitor to cut down on stomach acid. Could that be harmful?
    Komaroff AL
    Harv Health Lett; 2008 Jul; 33(9):8. PubMed ID: 18777657
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study.
    Berrutti M; Astegiano M; Smedile A; Fagoonee S; Rizzetto M; Pellicano R
    Panminerva Med; 2010 Dec; 52(4):361-2. PubMed ID: 21183897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.